Dr. Vadim Jucaud, United States
Do we predict mismatches that induce de novo DSA or do we predict the ones that do not?

Anat Tambur, United States
HLA molecular mismatch analysis in patients receiving kidney and the hematopoietic stem / facilitating cell induction protocol

Dr. Zhenyu Huo, People's Republic of China
Cancer risk in solid organ transplant recipients: A systematic review and meta-analysis

Dr. Nicole Louise De La Mata, Australia
Relative survival in kidney transplant recipients with de-novo cancers vs non-transplant cancer patients: A population study 1980-2016